These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3107815)

  • 1. Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
    Kemeny N; Reichman B; Dougherty J; Lipperman R; Cheng E
    Cancer Treat Rep; 1987 Jun; 71(6):663-4. PubMed ID: 3107815
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
    Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
    Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
    Eisenstaedt RS; Neilan BA; Bartolucci A
    Cancer Treat Rep; 1987; 71(7-8):779-80. PubMed ID: 3300971
    [No Abstract]   [Full Text] [Related]  

  • 4. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
    Cantrell JE; Hart RD; Taylor RF; Harvey JH
    Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
    Posner MR; Belliveau JF; Weitberg AB; Sabbath K; Wiemann MC; Cummings FJ; Calabresi P
    Cancer Treat Rep; 1987 Oct; 71(10):975-7. PubMed ID: 3308082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    De Forges A; Droz JP; Ghosn M; Theodore C
    Cancer Treat Rep; 1987 Nov; 71(11):1103. PubMed ID: 3119203
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ; Shani A; Rubin J; Moertel CG
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; Malfetano JH
    Gynecol Oncol; 1994 Apr; 53(1):24-6. PubMed ID: 8175017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
    Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
    Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 18. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
    O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
    Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.